Rapid, early and accurate SARS-CoV-2 detection using RT-qPCR in primary care: a prospective cohort study (REAP-1).


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
02 08 2021
Historique:
entrez: 3 8 2021
pubmed: 4 8 2021
medline: 5 8 2021
Statut: epublish

Résumé

We explore the importance of SARS-CoV-2 sentinel surveillance testing in primary care during a regional COVID-19 outbreak in Austria. Prospective cohort study. A single sentinel practice serving 22 829 people in the ski-resort of Schladming-Dachstein. All 73 patients presenting with mild-to-moderate flu-like symptoms between 24 February and 03 April, 2020. Nasopharyngeal sampling to detect SARS-CoV-2 using real-time reverse transcriptase-quantitative PCR (RT-qPCR). We compared RT-qPCR at presentation with confirmed antibody status. We split the outbreak in two parts, by halving the period from the first to the last case, to characterise three cohorts of patients with confirmed infection: early acute (RT-qPCR reactive) in the first half; and late acute (reactive) and late convalescent (non-reactive) in the second half. For each cohort, we report the number of cases detected, the accuracy of RT-qPCR, the duration and variety of symptoms, and the number of viral clades present. Twenty-two patients were diagnosed with COVID-19 (eight early acute, seven late acute and seven late convalescent), 44 patients tested SARS-CoV-2 negative and 7 were excluded. The sensitivity of RT-qPCR was 100% among all acute cases, dropping to 68.1% when including convalescent. Test specificity was 100%. Mean duration of symptoms for each group were 2 days (range 1-4) among early acute, 4.4 days (1-7) among late acute and 8 days (2-12) among late convalescent. Confirmed infection was associated with loss of taste. Acute infection was associated with loss of taste, nausea/vomiting, breathlessness, sore throat and myalgia; but not anosmia, fever or cough. Transmission clusters of three viral clades (G, GR and L) were identified. RT-qPCR testing in primary care can rapidly and accurately detect SARS-CoV-2 among people with flu-like illness in a heterogeneous viral outbreak. Targeted testing in primary care can support national sentinel surveillance of COVID-19.

Identifiants

pubmed: 34341034
pii: bmjopen-2020-045225
doi: 10.1136/bmjopen-2020-045225
pmc: PMC8331320
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e045225

Informations de copyright

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Emerg Infect Dis. 2020 Jun;26(6):1059-1066
pubmed: 32187007
Lancet Child Adolesc Health. 2020 Nov;4(11):817-827
pubmed: 32758453
Eur J Gen Pract. 2020 Dec;26(1):58-60
pubmed: 32349550
J Med Virol. 2021 Mar;93(3):1414-1420
pubmed: 32767703
Nature. 2020 May;581(7809):465-469
pubmed: 32235945
Science. 2020 May 1;368(6490):489-493
pubmed: 32179701
Lancet. 2021 Jan 9;397(10269):93-94
pubmed: 33347812
Ann Intern Med. 2020 Oct 20;173(8):672-675
pubmed: 32449883
Eur Arch Otorhinolaryngol. 2021 Mar;278(3):695-702
pubmed: 32844305
Sci Transl Med. 2020 Dec 9;12(573):
pubmed: 33229462
Am J Med Sci. 2021 Feb;361(2):216-225
pubmed: 33349441
Lancet Infect Dis. 2020 Jun;20(6):678-688
pubmed: 32213332
J R Soc Med. 2020 Nov;113(11):428-432
pubmed: 33108948
BMJ Open. 2020 Aug 5;10(8):e039856
pubmed: 32759252
Euro Surveill. 2020 Jan;25(3):
pubmed: 31992387
Ear Nose Throat J. 2020 Nov;99(9):569-576
pubmed: 32283980
Front Microbiol. 2020 Jul 22;11:1800
pubmed: 32793182
Implement Sci. 2015 Mar 30;10:42
pubmed: 25888928
ACS Chem Neurosci. 2020 Oct 7;11(19):2944-2961
pubmed: 32870641
Wellcome Open Res. 2020 Apr 9;5:67
pubmed: 32685698
BMJ. 2020 Jun 22;369:m2333
pubmed: 32571895
Lancet Infect Dis. 2020 Aug;20(8):911-919
pubmed: 32353347
Clin Infect Dis. 2020 Dec 17;71(10):2663-2666
pubmed: 32442256
Wien Klin Wochenschr. 2020 Nov;132(21-22):645-652
pubmed: 32816114
Curr Protoc Microbiol. 2020 Jun;57(1):e100
pubmed: 32302069
Ann Intern Med. 2020 May 5;172(9):577-582
pubmed: 32150748
Euro Surveill. 2017 Mar 30;22(13):
pubmed: 28382917
Lancet Microbe. 2021 Jan;2(1):e13-e22
pubmed: 33521734
Lancet Public Health. 2020 Aug;5(8):e452-e459
pubmed: 32682487
J Korean Med Sci. 2020 Apr 13;35(14):e149
pubmed: 32281317
Nat Med. 2020 Jul;26(7):1037-1040
pubmed: 32393804
Behav Res Methods. 2018 Aug;50(4):1694-1715
pubmed: 29667082

Auteurs

Werner Leber (W)

Wolfson Institute of Population Health, Centre for Primary Care, Queen Mary University of London, London, UK w.leber@qmul.ac.uk.

Oliver Lammel (O)

Praxis Dr Lammel, Ramsau am Dachstein, Austria.

Monika Redlberger-Fritz (M)

Center for Virology, Medical University of Vienna, Vienna, Austria.

Maria Elisabeth Mustafa-Korninger (ME)

Medizinisch-chemisches Labor Dr. Mustafa OG, Salzburg, Austria.

Reingard Christina Glehr (RC)

Institute of General Practice and Evidence-based Health Services Research, Medical University of Graz, Graz, Austria.

Jeremy Camp (J)

Center for Virology, Medical University of Vienna, Vienna, Austria.

Benedikt Agerer (B)

CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.

Alexander Lercher (A)

CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.

Alexandra Popa (A)

CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.

Jakob-Wendelin Genger (JW)

CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.

Thomas Penz (T)

CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.

Stephan Aberle (S)

Center for Virology, Medical University of Vienna, Vienna, Austria.

Christoph Bock (C)

CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.

Andreas Bergthaler (A)

CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.

Karin Stiasny (K)

Center for Virology, Medical University of Vienna, Vienna, Austria.

Eva-Maria Hochstrasser (EM)

Praxis Dr Lammel, Ramsau am Dachstein, Austria.

Christian Hoellinger (C)

Paracelsus Medical Private University, Salzburg, Austria.

Andrea Siebenhofer (A)

Institute of General Practice and Evidence-based Health Services Research, Medical University of Graz, Graz, Austria.
Goethe University Frankfurt, Institute for General Practice, Frankfurt, Germany.

Chris Griffiths (C)

Wolfson Institute of Population Health, Centre for Primary Care, Queen Mary University of London, London, UK.

Jasmina Panovska-Griffiths (J)

Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
The Queen's College, University of Oxford, Oxford, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH